Many serious diseases are present in the body long before symptoms appear. Despite that, many are caught too late.
Blood tests may catch them, if they’re done at the right time and you’re happy with the needle, the clinic and the wait.
Most of us aren’t.
Early skips all three, using a simple urine sample to screen multiple biomarkers at home, with results in minutes.
The Lab will be available to buy in limited numbers in Spring 2027, offered first to those who register interest
The first clinical-grade urine test you can use at home, screening for multiple biomarkers linked to some of today’s most prevalent serious diseases including diabetes and pre-diabetes, cancers of the bladder and urinary tract ,and problems in kidney function (alongside everyday wellness markers). Combining advanced science, elegant design and effortless usability, Early is designed to make regular health screening as routine as brushing your teeth. Results in under five minutes, from a device small enough to live on your bathroom shelf and beautiful enough that you’ll want it there. Not a needle in sight.
With Early You aren’t just buying a piece of tech. You are entering into a partnership with us and like all good partnerships, each side has a part to play*
*Your side of the deal: You pee on the test. That’s actually it
“We need to detect disease at a point when we can still cure it - less invasively and more kindly. That requires looking earlier than our current systems allow. Early is part of that answer”
Mark Emberton OBE
Professor of Interventional Oncology, UCL and former Dean of Medical Sciences, University College London. And Early’s Chief Medical Officer’
Frequently asked
questions
-
Early is developing a clinical-grade urine test you can use at home, built to surface the earliest warning signs of conditions such as urinary tract cancers, diabetes, and heart disease alongside wellness markers. Early is a working lab as much as a company and our scientists are actively working at the forefront of expanding the range of biomarkers we can measure at home. We'll share the full testing profile closer to launch.
-
Because honestly, who likes needles? Or months-long waiting times? Or the 8am scramble to get through to the doctor? Urine sidesteps all of that. It's information-rich, easy to collect, and can be tested privately at home, picking up meaningful changes day to day and surfacing the trends that make early detection possible.
-
Early is designed to plug a gap that, frankly, shouldn’t still exist. Wearables give you plenty of numbers, but not the ones that really matter. Clinical tests get into the detail (once you manage to get one), but only as a fixed snapshot in time. Early is designed for real life: clinical-grade results at home, easy to understand, with trends that build up over time. Built on the conviction that your health is too important to leave to tools that aren't fit for the job.
-
By securing a spot on the waitlist. That’s where pre-release access lives, and where the very first invitations to order will be sent.
-
About as much as a smart watch - with options designed to make regular testing affordable.
-
Spring 2027.